Displaying 1 - 8 of 8
Type
Year
Author

2025

Jeans AF
Padamsey Z
Collins HM
Foster W
Allison S
Dierksmeier S
Klein WL
van den Maagdenberg AMJM
Emptage NJ

Ca2.1 mediates presynaptic dysfunction induced by amyloid β oligomers.

2025. Cell Rep, 44(4):115451.

Collins HM
Gullino LS
Fuller C
Pinacho R
Bannerman DM
Sharp T

Increased c-Fos immunoreactivity in anxiety-related brain regions following paroxetine discontinuation.

2025. Neuropharmacology, 278:110541.

2024

Collins HM

Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.

2024. Int J Neuropsychopharmacol, 27(12).

Free Full Text at Europe PMC
PMC11635828
Full Text PDF
757.15 KB
Collins HM
Gullino LS
Ozdemir D
Lazarenco C
Sudarikova Y
Daly E
Pilar Cuéllar F
Pinacho R
Bannerman DM
Sharp T

Rebound activation of 5-HT neurons following SSRI discontinuation.

2024. Neuropsychopharmacology, 49(10):1580-1589.

Free Full Text at Europe PMC
PMC11319583
Full Text PDF
1.64 MB
Gullino LS
Fuller C
Dunn P
Collins HM
El Mestikawy S
Sharp T

Evidence for a Role of 5-HT-glutamate Co-releasing Neurons in Acute Stress Mechanisms.

2024. ACS Chem Neurosci, 15(6):1185-1196.

Free Full Text at Europe PMC
PMC10958520
Full Text PDF
12.56 MB
Sharp T
Collins HM

Mechanisms of SSRI Therapy and Discontinuation.

2024. Curr Top Behav Neurosci, 66:21-47.

2023

Collins HM
Pinacho R
Tam SKE
Sharp T
Bannerman DM
Peirson SN

Continuous home cage monitoring of activity and sleep in mice during repeated paroxetine treatment and discontinuation.

2023. Psychopharmacology (Berl), 240(11):2403-2418.

Free Full Text at Europe PMC
PMC10593620
Full Text PDF
1.23 MB

2022

Collins HM
Pinacho R
Ozdemir D
Bannerman DM
Sharp T

Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice.

2022. J Psychopharmacol, 36(7):794-805.

Free Full Text at Europe PMC
PMC9247435
Full Text PDF
678.61 KB